ArticleMolecular cancer therapeutics2012

Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification.

Justin M Balko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.